Your browser doesn't support javascript.
loading
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.
Okishige, Kaoru; Yamauchi, Yasuteru; Hanaki, Yuichi; Inoue, Koichi; Tanaka, Nobuaki; Yamaji, Hirosuke; Murakami, Takashi; Manita, Mamoru; Tabata, Kazuhiro; Ooie, Tatsuhiko; Tatsukawa, Youichi; Sakai, Hirotsuka; Yamaki, Masaru; Murakami, Masato; Takada, Takuma; Osaka, Yuki; Ono, Yuichi; Handa, Keita; Sugiyama, Koji; Yoshizawa, Tomoharu; Fukaya, Hidehira; Tashiro, Hideki; Takase, Susumu; Harada, Masahide; Watanabe, Eiichi; Yamane, Teiichi; Yamashita, Seigo; Aonuma, Kazutaka.
Afiliação
  • Okishige K; Japan Red Cross Yokohama City Bay Hospital, Kanagawa, Japan. okishige@yo.rim.or.jp.
  • Yamauchi Y; Japan Red Cross Yokohama City Bay Hospital, Kanagawa, Japan.
  • Hanaki Y; University of Tsukuba School of Medicine, Ibaraki, Japan.
  • Inoue K; Sakurabashi Watanabe Hospital, Osaka, Japan.
  • Tanaka N; Sakurabashi Watanabe Hospital, Osaka, Japan.
  • Yamaji H; Okayama Heart Clinic, Okayama, Japan.
  • Murakami T; Okayama Heart Clinic, Okayama, Japan.
  • Manita M; Naha City Hospital, Okinawa, Japan.
  • Tabata K; Naha City Hospital, Okinawa, Japan.
  • Ooie T; Oita Oka Hospital, Oita, Japan.
  • Tatsukawa Y; Oita Oka Hospital, Oita, Japan.
  • Sakai H; Nayoro City General Hospital, Hokkaido, Japan.
  • Yamaki M; Nayoro City General Hospital, Hokkaido, Japan.
  • Murakami M; Shonan Kamakura General Hospital, Kanagawa, Japan.
  • Takada T; Shonan Kamakura General Hospital, Kanagawa, Japan.
  • Osaka Y; Ome Municipal General Hospital, Tokyo, Japan.
  • Ono Y; Ome Municipal General Hospital, Tokyo, Japan.
  • Handa K; Kashiwa Municipal Hospital, Chiba, Japan.
  • Sugiyama K; Kashiwa Municipal Hospital, Chiba, Japan.
  • Yoshizawa T; Kitasato University School of Medicine, Kanagawa, Japan.
  • Fukaya H; Kitasato University School of Medicine, Kanagawa, Japan.
  • Tashiro H; St.Mary's Hospital, Fukuoka, Japan.
  • Takase S; St.Mary's Hospital, Fukuoka, Japan.
  • Harada M; Fujita Health University School of Medicine, Aichi, Japan.
  • Watanabe E; Fujita Health University School of Medicine, Aichi, Japan.
  • Yamane T; Jikei University School of Medicine, Tokyo, Japan.
  • Yamashita S; Jikei University School of Medicine, Tokyo, Japan.
  • Aonuma K; University of Tsukuba School of Medicine, Ibaraki, Japan.
J Thromb Thrombolysis ; 47(4): 487-494, 2019 May.
Article em En | MEDLINE | ID: mdl-30955142
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tamponamento Cardíaco / Ablação por Cateter / Anticorpos Monoclonais Humanizados / Dabigatrana Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thromb Thrombolysis Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tamponamento Cardíaco / Ablação por Cateter / Anticorpos Monoclonais Humanizados / Dabigatrana Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thromb Thrombolysis Ano de publicação: 2019 Tipo de documento: Article